P/E at 60.66 vs Industry's 59.61: What the Data Shows for Apollo Hospitals Enterprise Ltd.

2 hours ago

Share Via

A price-to-earnings ratio of 60.66 against an industry average of 59.61 represents a modest premium for Apollo Hospitals Enterprise Ltd.. Previously rated Hold by MarketsMojo, the company’s rating was reassessed on 13 Apr 2026. While the one-year return of 6.65% comfortably outpaces the Sensex’s decline of 2.79%, the stock’s recent momentum shows a more nuanced picture with a 3-month gain of 11.99% contrasting the broader market’s 4.49% loss. The data reveals a stock balancing valuation premium with mixed performance signals across timeframes.

Valuation Picture: Premium Reflecting Sector Confidence

Apollo Hospitals Enterprise Ltd. trades at a P/E of 60.66, slightly above the hospital industry’s average of 59.61. This premium, though not extreme, suggests investors are willing to pay a bit more for the company’s earnings relative to peers. The market capitalisation stands at a substantial ₹1,09,517.18 crores, underscoring its large-cap status within the hospital sector. Such a valuation premium often reflects expectations of superior earnings growth or operational resilience, but it also raises questions about sustainability amid sector headwinds. Previously rated Hold, what is Apollo Hospitals’ current rating given this valuation context?

Performance Across Timeframes: Divergent Momentum

The stock’s performance over the past year has been positive, with a 6.65% gain compared to the Sensex’s 2.79% decline, signalling relative strength. Year-to-date, the stock has advanced 8.15%, again outperforming the Sensex’s 8.62% loss. Over longer horizons, Apollo Hospitals has delivered robust returns: 74.65% over three years, 137.94% over five years, and an impressive 459.79% over ten years, all well ahead of the Sensex’s respective 30.55%, 62.66%, and 201.41% gains.

However, the short-term picture is more complex. The stock’s 3-month return of 11.99% sharply contrasts with the Sensex’s 4.49% decline, indicating strong recent momentum. Meanwhile, the 1-month gain of 6.63% slightly trails the Sensex’s 7.13% rise. The 1-week performance shows a modest 0.80% increase versus a marginal 0.14% drop in the Sensex, while the 1-day change is a slight decline of 0.62%, though still outperforming the Sensex’s 0.81% fall. This divergence between short and medium-term returns raises the question of whether the recent rally is sustainable or a temporary surge — is this a genuine recovery or a relief rally that will fade at the 50 DMA?

Moving Average Configuration: Bullish Across All Key Averages

Technically, Apollo Hospitals is trading above all major moving averages: 5-day, 20-day, 50-day, 100-day, and 200-day. This comprehensive positioning suggests a strong upward trend and confirms the recent positive momentum seen in the 3-month and 1-month returns. Being above the 200-day moving average is particularly significant as it often signals a sustained bullish phase rather than a short-lived bounce. This technical strength supports the valuation premium, but the question remains whether the stock can maintain this trajectory amid sector volatility — should investors in Apollo Hospitals hold, buy more, or reconsider?

Sector Performance Context: Hospital Industry Mixed but Leaning Positive

The hospital sector has shown a mixed performance recently, with some companies reporting positive results while others remain flat or negative. Apollo Hospitals stands out with its consistent outperformance over the Sensex and its peers. The sector’s average P/E of 59.61 reflects moderate valuation levels, and Apollo’s slight premium indicates confidence in its operational capabilities and growth prospects. The sector’s mixed results highlight the importance of company-specific factors in driving stock performance rather than broad sector trends alone.

Rating Reassessment: Previously Hold, Now Updated

MarketsMOJO had previously rated Apollo Hospitals Enterprise Ltd. as Hold. The rating was reassessed on 13 Apr 2026, reflecting the evolving data on valuation, performance, and technical indicators. This reassessment takes into account the stock’s premium valuation, strong long-term returns, and bullish moving average configuration. The updated rating invites investors to reconsider their stance on the stock in light of these factors — what is the current rating for Apollo Hospitals given this comprehensive data?

Conclusion: Data Reflects a Stock Balancing Premium Valuation and Strong Technicals

The data for Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a slight premium to its sector’s P/E, supported by strong long-term returns and a bullish technical setup. The stock’s outperformance over the past year and its positioning above all major moving averages indicate resilience and positive momentum. However, the valuation premium and mixed short-term performance invite scrutiny regarding sustainability. The recent rating reassessment from Hold reflects these nuanced factors, encouraging investors to weigh valuation against technical strength carefully.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)

MOJO SCORE